Uttar Pradesh Medical Health and Family Welfare Department Muzaffarnagar Injectable Medicines Tender 2026 - Inj. Renocrit-4000IU, D-25, Pam Care, Sucol, Labetalol

Tender Overview

The Uttar Pradesh Medical Health and Family Welfare Department invites bids for the supply of injectable medicines including Inj. Renocrit-4000IU, Inj. D-25, Inj. Pam care, Inj. Sucol, and Inj. Labetalol to support medical facilities in Muzaffarnagar, Uttar Pradesh 247771. The procurement scope covers multiple items (5 BOQ entries) with quantity variations possible up to 25% of the bid quantity, both at order placement and during the currency of the contract. The tender emphasizes compliance with delivery timelines linked to extended quantities, and requires bidders to meet turnover criteria as described in the bid document. The contract is expected to align with government procurement practices, ensuring supply reliability for essential injectable medicines. This opportunity targets pharmaceutical suppliers capable of meeting strict delivery and financial benchmarks, while maintaining consistent quality control for hospital use in UP. Unique aspects include an option-based delivery framework and a turnover verification requirement, with the overall aim of ensuring uninterrupted access to critical injectables.

Technical Specifications & Requirements

• Product names: Inj. Renocrit-4000IU, Inj. D-25, Inj. Pam care, Inj. Sucol, Inj. Labetalol
• Delivery option: Up to 25% quantity increase during contract period; delivery period adjustments based on activity
• Turnover criterion: Minimum average annual turnover for the last three financial years as specified in the bid document; evidence via audited balance sheets or CA/CMA certificate
• Evidence required: Certified audited financial statements or CA/Cost Accountant certificate; turnover evaluated if bidder is under 3 years since incorporation
• Geographic focus: Muzaffarnagar, Uttar Pradesh; procurement supports state health facilities
• BoQ status: 5 items listed with no explicit quantity; bidders must align with organization’s demand and delivery commitments
• Quality/legibility: Compliance with standard procurement practices; emphasis on timely supply and financial credibility
• Warranty/aftercare: Not explicitly specified; bidders should infer standard supplier obligations from government terms

Terms, Conditions & Eligibility

• EMD/submission: Not explicitly stated in data; bidders must satisfy typical EMD requirements per government norms
• Turnover proof: Must provide turnover details for last three financial years via audited statements or CA/CMA certificate
• Delivery schedule: Delivery period linked to last date of original delivery order; option-based extension with minimum 30 days
• Payment terms: Not specified in data; bidders should anticipate standard government practice (milestones on delivery)
• BOQ/Items: 5 items; no explicit quantities; align bids to stated items and ensure availability of injectables
• Compliance: Bidders must comply with the Buyer Added Terms; including option clause and delivery time calculation
• Eligibility: Based on turnover, ability to supply injectables of specified medicines, and financial credibility